ASMB — ASSEMBLY BIOSCIENCES INC

Ownership history in B Group, Inc. · 5 quarters on record

This page tracks every 13F SEC filing in which B Group, Inc. reported a position in ASSEMBLY BIOSCIENCES INC (ASMB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position

4.41% (2025 Q4)

Avg. % of fund

2.5%

First filed

2024 Q4

Last filed

2025 Q4

Quarters held

5

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2025 Q4	UNCHANGED	175,706	—	0%	4.41%	$6.0M	$34.01
2025 Q3	REDUCED	175,706	-13,644	-7.2%	3.31%	$4.5M	$25.60
2025 Q2	REDUCED	189,350	-10,650	-5.3%	2.64%	$3.4M	$18.12
2025 Q1	ADDED	200,000	+149,349	+294.9%	1.64%	$1.9M	$9.56

% of Fund (quarterly) ASMB price (monthly, adj. close)

Other funds also holding ASMB

As of 2025 Q4 — sorted by position size

GILEAD SCIENCES, INC. 7.92% Commodore Capital LP 3Y 2.26% SUPERSTRING CAPITAL MANAGEMENT LP 1.19% Patient Square Capital LP 3Y 0.92% STEMPOINT CAPITAL LP 0.91% MONIMUS CAPITAL MANAGEMENT, LP 0.86% Parkman Healthcare Partners LLC 3Y 0.81% Paradigm Biocapital Advisors LP 3Y 0.58% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.36% Palumbo Wealth Management LLC 3Y 0.31%

← Back to B Group, Inc. Holdings